TrialFind
Saved trials
Back to results
Completed
Phase 3
The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning
NCT00566735
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
Massachusetts General Hospital
Boston, Massachusetts, United States
View on ClinicalTrials.gov
Official details
The Use of Galantamine HBr (Reminyl) in Electroconvulsive Therapy: Impact on Mood and Cognitive Functioning — TrialFind